nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.087	0.123	CbGbCtD
Montelukast—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0572	0.0807	CbGbCtD
Montelukast—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0388	0.0548	CbGbCtD
Montelukast—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0388	0.0548	CbGbCtD
Montelukast—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0318	0.0449	CbGbCtD
Montelukast—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0299	0.0423	CbGbCtD
Montelukast—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0299	0.0423	CbGbCtD
Montelukast—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0294	0.0415	CbGbCtD
Montelukast—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0294	0.0415	CbGbCtD
Montelukast—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0282	0.0398	CbGbCtD
Montelukast—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0271	0.0382	CbGbCtD
Montelukast—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0271	0.0382	CbGbCtD
Montelukast—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0234	0.033	CbGbCtD
Montelukast—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0227	0.032	CbGbCtD
Montelukast—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0205	0.029	CbGbCtD
Montelukast—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0205	0.029	CbGbCtD
Montelukast—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0197	0.0278	CbGbCtD
Montelukast—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0185	0.0261	CbGbCtD
Montelukast—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0174	0.0246	CbGbCtD
Montelukast—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0174	0.0246	CbGbCtD
Montelukast—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0157	0.0222	CbGbCtD
Montelukast—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0157	0.0222	CbGbCtD
Montelukast—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0192	CbGbCtD
Montelukast—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.0186	CbGbCtD
Montelukast—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0168	CbGbCtD
Montelukast—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0168	CbGbCtD
Montelukast—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0114	0.0161	CbGbCtD
Montelukast—CYSLTR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00207	0.0442	CbGeAlD
Montelukast—CYSLTR1—blood—acquired immunodeficiency syndrome	0.00195	0.0416	CbGeAlD
Montelukast—CYSLTR1—bone marrow—acquired immunodeficiency syndrome	0.00189	0.0403	CbGeAlD
Montelukast—CYSLTR1—vagina—acquired immunodeficiency syndrome	0.00181	0.0386	CbGeAlD
Montelukast—CYSLTR1—lung—acquired immunodeficiency syndrome	0.00171	0.0365	CbGeAlD
Montelukast—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.0016	0.034	CbGeAlD
Montelukast—CYSLTR1—nervous system—acquired immunodeficiency syndrome	0.00158	0.0338	CbGeAlD
Montelukast—CYSLTR1—central nervous system—acquired immunodeficiency syndrome	0.00153	0.0325	CbGeAlD
Montelukast—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00146	0.0311	CbGeAlD
Montelukast—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00142	0.0302	CbGeAlD
Montelukast—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00129	0.0276	CbGeAlD
Montelukast—ALOX5—lymphoid tissue—acquired immunodeficiency syndrome	0.00126	0.0268	CbGeAlD
Montelukast—ALOX5—digestive system—acquired immunodeficiency syndrome	0.00124	0.0264	CbGeAlD
Montelukast—CYSLTR1—brain—acquired immunodeficiency syndrome	0.00121	0.0258	CbGeAlD
Montelukast—ALOX5—blood—acquired immunodeficiency syndrome	0.00118	0.0252	CbGeAlD
Montelukast—CYSLTR1—lymph node—acquired immunodeficiency syndrome	0.00117	0.0249	CbGeAlD
Montelukast—ALOX5—bone marrow—acquired immunodeficiency syndrome	0.00114	0.0244	CbGeAlD
Montelukast—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00108	0.0231	CbGeAlD
Montelukast—ALOX5—lung—acquired immunodeficiency syndrome	0.00104	0.0221	CbGeAlD
Montelukast—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000966	0.0206	CbGeAlD
Montelukast—ALOX5—nervous system—acquired immunodeficiency syndrome	0.000959	0.0205	CbGeAlD
Montelukast—SLCO2B1—digestive system—acquired immunodeficiency syndrome	0.000955	0.0204	CbGeAlD
Montelukast—ALOX5—central nervous system—acquired immunodeficiency syndrome	0.000924	0.0197	CbGeAlD
Montelukast—CYP2A6—lung—acquired immunodeficiency syndrome	0.000914	0.0195	CbGeAlD
Montelukast—SLCO2B1—spinal cord—acquired immunodeficiency syndrome	0.000877	0.0187	CbGeAlD
Montelukast—SLCO2B1—lung—acquired immunodeficiency syndrome	0.000798	0.017	CbGeAlD
Montelukast—SLCO2B1—nervous system—acquired immunodeficiency syndrome	0.000739	0.0157	CbGeAlD
Montelukast—ALOX5—brain—acquired immunodeficiency syndrome	0.000733	0.0156	CbGeAlD
Montelukast—SLCO2B1—central nervous system—acquired immunodeficiency syndrome	0.000711	0.0152	CbGeAlD
Montelukast—ALOX5—lymph node—acquired immunodeficiency syndrome	0.000709	0.0151	CbGeAlD
Montelukast—CYP2A6—brain—acquired immunodeficiency syndrome	0.000647	0.0138	CbGeAlD
Montelukast—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000623	0.0133	CbGeAlD
Montelukast—CYP2C8—blood—acquired immunodeficiency syndrome	0.000585	0.0125	CbGeAlD
Montelukast—SLCO2B1—brain—acquired immunodeficiency syndrome	0.000565	0.012	CbGeAlD
Montelukast—SLCO2B1—lymph node—acquired immunodeficiency syndrome	0.000546	0.0116	CbGeAlD
Montelukast—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000545	0.0116	CbGeAlD
Montelukast—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000542	0.0116	CbGeAlD
Montelukast—CYP2C9—blood—acquired immunodeficiency syndrome	0.00052	0.0111	CbGeAlD
Montelukast—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000498	0.0106	CbGeAlD
Montelukast—PTGS1—blood—acquired immunodeficiency syndrome	0.000474	0.0101	CbGeAlD
Montelukast—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000457	0.00974	CbGeAlD
Montelukast—PTGS1—vagina—acquired immunodeficiency syndrome	0.00044	0.00937	CbGeAlD
Montelukast—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000416	0.00887	CbGeAlD
Montelukast—PTGS1—lung—acquired immunodeficiency syndrome	0.000416	0.00886	CbGeAlD
Montelukast—CYP3A4—blood—acquired immunodeficiency syndrome	0.000396	0.00845	CbGeAlD
Montelukast—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000385	0.00821	CbGeAlD
Montelukast—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000371	0.0079	CbGeAlD
Montelukast—CYP2C8—brain—acquired immunodeficiency syndrome	0.000363	0.00774	CbGeAlD
Montelukast—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000322	0.00686	CbGeAlD
Montelukast—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00031	0.0066	CbGeAlD
Montelukast—PTGS1—brain—acquired immunodeficiency syndrome	0.000294	0.00627	CbGeAlD
Montelukast—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000284	0.00606	CbGeAlD
Montelukast—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.000878	CcSEcCtD
Montelukast—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000214	0.000876	CcSEcCtD
Montelukast—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000214	0.000876	CcSEcCtD
Montelukast—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000873	CcSEcCtD
Montelukast—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000213	0.000869	CcSEcCtD
Montelukast—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000862	CcSEcCtD
Montelukast—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000211	0.000861	CcSEcCtD
Montelukast—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00021	0.000858	CcSEcCtD
Montelukast—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000857	CcSEcCtD
Montelukast—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000857	CcSEcCtD
Montelukast—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000856	CcSEcCtD
Montelukast—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.000854	CcSEcCtD
Montelukast—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000207	0.000844	CcSEcCtD
Montelukast—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.000844	CcSEcCtD
Montelukast—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.000843	CcSEcCtD
Montelukast—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000842	CcSEcCtD
Montelukast—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000841	CcSEcCtD
Montelukast—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00084	CcSEcCtD
Montelukast—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.000836	CcSEcCtD
Montelukast—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000205	0.000836	CcSEcCtD
Montelukast—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000834	CcSEcCtD
Montelukast—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000203	0.000831	CcSEcCtD
Montelukast—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000203	0.000829	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000203	0.000828	CcSEcCtD
Montelukast—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000202	0.000824	CcSEcCtD
Montelukast—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000202	0.000824	CcSEcCtD
Montelukast—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000824	CcSEcCtD
Montelukast—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000823	CcSEcCtD
Montelukast—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000822	CcSEcCtD
Montelukast—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000822	CcSEcCtD
Montelukast—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000822	CcSEcCtD
Montelukast—Rash—Didanosine—acquired immunodeficiency syndrome	0.0002	0.000817	CcSEcCtD
Montelukast—Infection—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000817	CcSEcCtD
Montelukast—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.0002	0.000816	CcSEcCtD
Montelukast—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0002	0.000816	CcSEcCtD
Montelukast—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0002	0.000816	CcSEcCtD
Montelukast—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000813	CcSEcCtD
Montelukast—Headache—Didanosine—acquired immunodeficiency syndrome	0.000199	0.000812	CcSEcCtD
Montelukast—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.00081	CcSEcCtD
Montelukast—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000808	CcSEcCtD
Montelukast—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000198	0.000807	CcSEcCtD
Montelukast—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000807	CcSEcCtD
Montelukast—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000805	CcSEcCtD
Montelukast—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000801	CcSEcCtD
Montelukast—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000196	0.0008	CcSEcCtD
Montelukast—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000196	0.000799	CcSEcCtD
Montelukast—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000798	CcSEcCtD
Montelukast—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000195	0.000798	CcSEcCtD
Montelukast—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000195	0.000797	CcSEcCtD
Montelukast—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000195	0.000796	CcSEcCtD
Montelukast—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000195	0.000795	CcSEcCtD
Montelukast—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000793	CcSEcCtD
Montelukast—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000793	CcSEcCtD
Montelukast—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.00079	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000787	CcSEcCtD
Montelukast—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000785	CcSEcCtD
Montelukast—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000192	0.000784	CcSEcCtD
Montelukast—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000784	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000783	CcSEcCtD
Montelukast—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000782	CcSEcCtD
Montelukast—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000781	CcSEcCtD
Montelukast—Pain—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000778	CcSEcCtD
Montelukast—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000777	CcSEcCtD
Montelukast—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.000777	CcSEcCtD
Montelukast—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000777	CcSEcCtD
Montelukast—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.000773	CcSEcCtD
Montelukast—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.000773	CcSEcCtD
Montelukast—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.000772	CcSEcCtD
Montelukast—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.000771	CcSEcCtD
Montelukast—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000188	0.00077	CcSEcCtD
Montelukast—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000188	0.00077	CcSEcCtD
Montelukast—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000764	CcSEcCtD
Montelukast—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000763	CcSEcCtD
Montelukast—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000763	CcSEcCtD
Montelukast—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000761	CcSEcCtD
Montelukast—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00076	CcSEcCtD
Montelukast—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000186	0.000758	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000758	CcSEcCtD
Montelukast—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000756	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000749	CcSEcCtD
Montelukast—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000746	CcSEcCtD
Montelukast—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000183	0.000746	CcSEcCtD
Montelukast—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000745	CcSEcCtD
Montelukast—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000744	CcSEcCtD
Montelukast—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000182	0.000744	CcSEcCtD
Montelukast—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000182	0.000744	CcSEcCtD
Montelukast—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000743	CcSEcCtD
Montelukast—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000742	CcSEcCtD
Montelukast—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000741	CcSEcCtD
Montelukast—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000181	0.000741	CcSEcCtD
Montelukast—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000741	CcSEcCtD
Montelukast—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000738	CcSEcCtD
Montelukast—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.000738	CcSEcCtD
Montelukast—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000735	CcSEcCtD
Montelukast—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00018	0.000735	CcSEcCtD
Montelukast—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00018	0.000734	CcSEcCtD
Montelukast—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000179	0.000733	CcSEcCtD
Montelukast—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000732	CcSEcCtD
Montelukast—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000731	CcSEcCtD
Montelukast—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000179	0.00073	CcSEcCtD
Montelukast—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000728	CcSEcCtD
Montelukast—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000728	CcSEcCtD
Montelukast—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000727	CcSEcCtD
Montelukast—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000726	CcSEcCtD
Montelukast—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000724	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000723	CcSEcCtD
Montelukast—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000722	CcSEcCtD
Montelukast—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000719	CcSEcCtD
Montelukast—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000719	CcSEcCtD
Montelukast—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000717	CcSEcCtD
Montelukast—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000176	0.000717	CcSEcCtD
Montelukast—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000716	CcSEcCtD
Montelukast—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000175	0.000715	CcSEcCtD
Montelukast—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.000711	CcSEcCtD
Montelukast—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.000711	CcSEcCtD
Montelukast—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000711	CcSEcCtD
Montelukast—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00071	CcSEcCtD
Montelukast—Rash—Stavudine—acquired immunodeficiency syndrome	0.000174	0.000709	CcSEcCtD
Montelukast—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000709	CcSEcCtD
Montelukast—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000173	0.000709	CcSEcCtD
Montelukast—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000173	0.000707	CcSEcCtD
Montelukast—Headache—Stavudine—acquired immunodeficiency syndrome	0.000173	0.000705	CcSEcCtD
Montelukast—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000172	0.000705	CcSEcCtD
Montelukast—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000703	CcSEcCtD
Montelukast—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.000702	CcSEcCtD
Montelukast—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.000701	CcSEcCtD
Montelukast—Rash—Abacavir—acquired immunodeficiency syndrome	0.000171	0.000699	CcSEcCtD
Montelukast—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000171	0.000698	CcSEcCtD
Montelukast—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000698	CcSEcCtD
Montelukast—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000698	CcSEcCtD
Montelukast—Headache—Abacavir—acquired immunodeficiency syndrome	0.00017	0.000694	CcSEcCtD
Montelukast—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000693	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000693	CcSEcCtD
Montelukast—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000169	0.000692	CcSEcCtD
Montelukast—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.000692	CcSEcCtD
Montelukast—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000687	CcSEcCtD
Montelukast—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000684	CcSEcCtD
Montelukast—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000683	CcSEcCtD
Montelukast—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000683	CcSEcCtD
Montelukast—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000682	CcSEcCtD
Montelukast—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000679	CcSEcCtD
Montelukast—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000679	CcSEcCtD
Montelukast—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000678	CcSEcCtD
Montelukast—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000676	CcSEcCtD
Montelukast—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000672	CcSEcCtD
Montelukast—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000164	0.00067	CcSEcCtD
Montelukast—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000164	0.00067	CcSEcCtD
Montelukast—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000669	CcSEcCtD
Montelukast—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000164	0.000669	CcSEcCtD
Montelukast—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000164	0.000668	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000667	CcSEcCtD
Montelukast—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000662	CcSEcCtD
Montelukast—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000161	0.000658	CcSEcCtD
Montelukast—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000657	CcSEcCtD
Montelukast—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000656	CcSEcCtD
Montelukast—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000655	CcSEcCtD
Montelukast—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000653	CcSEcCtD
Montelukast—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000652	CcSEcCtD
Montelukast—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.00065	CcSEcCtD
Montelukast—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00065	CcSEcCtD
Montelukast—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.00065	CcSEcCtD
Montelukast—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.00065	CcSEcCtD
Montelukast—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.000647	CcSEcCtD
Montelukast—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000644	CcSEcCtD
Montelukast—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000643	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000636	CcSEcCtD
Montelukast—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.000633	CcSEcCtD
Montelukast—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000632	CcSEcCtD
Montelukast—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000631	CcSEcCtD
Montelukast—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000631	CcSEcCtD
Montelukast—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000627	CcSEcCtD
Montelukast—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000626	CcSEcCtD
Montelukast—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000622	CcSEcCtD
Montelukast—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.000622	CcSEcCtD
Montelukast—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000622	CcSEcCtD
Montelukast—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.00062	CcSEcCtD
Montelukast—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000616	CcSEcCtD
Montelukast—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000616	CcSEcCtD
Montelukast—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000616	CcSEcCtD
Montelukast—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000614	CcSEcCtD
Montelukast—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.000612	CcSEcCtD
Montelukast—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000608	CcSEcCtD
Montelukast—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000606	CcSEcCtD
Montelukast—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000604	CcSEcCtD
Montelukast—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000603	CcSEcCtD
Montelukast—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000602	CcSEcCtD
Montelukast—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000601	CcSEcCtD
Montelukast—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000601	CcSEcCtD
Montelukast—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000601	CcSEcCtD
Montelukast—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000598	CcSEcCtD
Montelukast—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000597	CcSEcCtD
Montelukast—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.00059	CcSEcCtD
Montelukast—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000588	CcSEcCtD
Montelukast—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000582	CcSEcCtD
Montelukast—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000581	CcSEcCtD
Montelukast—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000142	0.000581	CcSEcCtD
Montelukast—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000578	CcSEcCtD
Montelukast—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000578	CcSEcCtD
Montelukast—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000578	CcSEcCtD
Montelukast—Rash—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000573	CcSEcCtD
Montelukast—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000573	CcSEcCtD
Montelukast—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000571	CcSEcCtD
Montelukast—Headache—Indinavir—acquired immunodeficiency syndrome	0.000139	0.00057	CcSEcCtD
Montelukast—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000568	CcSEcCtD
Montelukast—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000562	CcSEcCtD
Montelukast—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.00056	CcSEcCtD
Montelukast—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000554	CcSEcCtD
Montelukast—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000552	CcSEcCtD
Montelukast—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000552	CcSEcCtD
Montelukast—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000546	CcSEcCtD
Montelukast—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000545	CcSEcCtD
Montelukast—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000544	CcSEcCtD
Montelukast—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000542	CcSEcCtD
Montelukast—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000541	CcSEcCtD
Montelukast—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000132	0.00054	CcSEcCtD
Montelukast—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000539	CcSEcCtD
Montelukast—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000538	CcSEcCtD
Montelukast—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000538	CcSEcCtD
Montelukast—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000525	CcSEcCtD
Montelukast—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000523	CcSEcCtD
Montelukast—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.00052	CcSEcCtD
Montelukast—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000518	CcSEcCtD
Montelukast—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000518	CcSEcCtD
Montelukast—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000518	CcSEcCtD
Montelukast—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000515	CcSEcCtD
Montelukast—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000514	CcSEcCtD
Montelukast—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.00051	CcSEcCtD
Montelukast—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000503	CcSEcCtD
Montelukast—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000501	CcSEcCtD
Montelukast—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000501	CcSEcCtD
Montelukast—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000494	CcSEcCtD
Montelukast—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000488	CcSEcCtD
Montelukast—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000484	CcSEcCtD
Montelukast—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000483	CcSEcCtD
Montelukast—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000479	CcSEcCtD
Montelukast—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000479	CcSEcCtD
Montelukast—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000478	CcSEcCtD
Montelukast—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000476	CcSEcCtD
Montelukast—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000465	CcSEcCtD
Montelukast—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000462	CcSEcCtD
Montelukast—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000461	CcSEcCtD
Montelukast—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000461	CcSEcCtD
Montelukast—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000458	CcSEcCtD
Montelukast—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000451	CcSEcCtD
Montelukast—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000444	CcSEcCtD
Montelukast—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00044	CcSEcCtD
Montelukast—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00044	CcSEcCtD
Montelukast—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000437	CcSEcCtD
Montelukast—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000435	CcSEcCtD
Montelukast—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000415	CcSEcCtD
